🟢 ADMA Biologics is trading 4.1% up today despite no clear company-specific news catalyst

ADMA Biologics is trading at $9.02 (4.1% up) in after-hours trading despite a lack of fresh, company-specific headlines such as earnings, FDA decisions, or major deals.

• The move appears driven by a strong broader market backdrop and general risk-on sentiment rather than a fundamental ADMA-specific catalyst.
• Price action may be amplified by typical after-hours dynamics, including lower liquidity and heightened sensitivity to modest buying interest.